​

Novel transcatheter therapy to remodel the annulus of the mitral and tricuspid valves via application of proprietary

levels of applied energy with assisted direct visualization and proprietary device technologies to achieve more

complete valvular leaflet apposition post treatment, and reduce or eliminate valvular insufficiency in Functional

Mitral and Tricuspid regurgitation patients.